Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes by Glauser, Dominique A et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Molecular Biology
Open Access Research article
Transcriptional response of pancreatic beta cells to metabolic 
stimulation: large scale identification of immediate-early and 
secondary response genes
Dominique A Glauser1, Thierry Brun2, Benoit R Gauthier2 and 
Werner Schlegel*1
Address: 1Fondation pour Recherches Médicales, University of Geneva, Av. de la Roseraie 64, 1211 Geneva, Switzerland and 2Department of Cell 
Physiology and Metabolism, University Medical Center, Rue Michel-Servet 1, 1211 Geneva, Switzerland
Email: Dominique A Glauser - dominique.glauser@medecine.unige.ch; Thierry Brun - thierry.brun@medecine.unige.ch; 
Benoit R Gauthier - benoit.gauthier@medecine.unige.ch; Werner Schlegel* - werner.schlegel@medecine.unige.ch
* Corresponding author    
Abstract
Background: Physiological long term adaptation of pancreatic beta cells is driven by stimuli such
as glucose and incretin hormones acting via cAMP (e.g. GLP-1) and involves regulated gene
expression. Several rapidly inducible immediate-early genes (IEGs) have been identified in beta cells.
Many of these IEGs code for transcription factors and have the potential to control the
transcription of downstream target genes likely involved in long term cellular adaptation. The
identity of these target genes has not been determined, and the sequence of events occurring during
beta cell adaptation is still unclear.
Results: We have developed a microarray-based strategy for the systematic search of targets. In
Min6 insulin-secreting cells, we identified 592 targets and 1278 IEGs responding to a co-stimulation
with glucose and cAMP. Both IEGs and targets were involved in a large panel of functions, including
those important to beta cell physiology (metabolism, secretion). Nearly 200 IEGs were involved in
signaling and transcriptional regulation. To find specific examples of the regulatory link between
IEGs and targets, target promoter sequences were analyzed in silico. Statistically significant over-
representation of AP-1 response elements notably suggested an important role for this
transcription factor, which was experimentally verified. Indeed, cell stimulation altered expression
of IEG-encoded components of the AP-1 complex, activating AP-1-dependent transcription. Loss
and gain-of-function experiments furthermore allowed to validate a new AP-1 regulated gene
(sulfiredoxin) among the targets. AP-1 and sulfiredoxin are sequentially induced also in primary cells
from rat islets of Langerhans.
Conclusion: By identifying IEGs and their downstream targets, this study brings a comprehensive
description of the transcriptional response occurring after beta cell stimulation, as well as new
mechanistic insights concerning the AP-1 transcription factor.
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Background
In mammals, blood glucose homeostasis is subjected to a
tight endocrine control relying notably on insulin-pro-
ducing beta cells from the pancreas. Beta cells secrete insu-
lin in response to increased glucose concentrations and to
hormones released from gut cells, like glucagon-like pep-
tide-1 (GLP-1). In longer term, these physiological signals
also control insulin production, stimuli-responsiveness
and beta cell mass [1-4]. Over the years, this regulation
helps the organism maintaining glucose homeostasis,
accommodating changes in diet and insulin demand.
Deficient adaptation may lead to diabetes [5,6].
Long term adaptation of beta cell is associated with
changes in gene transcription. Several glucose-regulated
genes have been identified which are likely involved in the
chronic effects of glucose on beta cell mass and function
[3,7,8]. Some of these genes are immediate-early response
genes (IEGs) rapidly induced upon acute beta cell stimu-
lation with glucose and other stimuli [7,9,10].
IEGs are defined as genes which transcription is regulated
without the need for protein de novo synthesis. Induction
of IEG transcription is triggered by intracellular signals
which activate constitutively expressed transcription fac-
tors acting on IEG promoters [11,12]. In beta cells, the
mechanisms leading to the induction of IEGs by glucose
and GLP-1 were shown to involve generation of cAMP, as
well as cell depolarization and subsequent Ca2+ signaling,
resulting in activation of calmodulin-dependent kinase
IV, protein kinase A and extracellular signal-regulated
kinase 1/2. These kinases lead to phosphorylation and
activation of several transcription factors, like cAMP-
responsive element binding protein, serum response fac-
tor, and Elk-1 [13-16]. These mechanisms occur rapidly
and result, within minutes, in transcriptional regulation
of IEGs. Such direct and rapid mechanisms do not how-
ever permit to understand regulation of genes for which
expression levels change later and over much longer time
frames (hours, days), and which are likely relevant for the
long term adaptation of beta cell. Other types of mecha-
nisms must be taken into account.
The best studied IEGs in beta cells (e.g. c-fos, egr-1, nur77,
c-myc) code for transcription factors [7,9,10,17]. It has
been proposed that these transcription factors will in turn
regulate the transcription of downstream target genes
(which will be referred as targets throughout this manu-
script). The distinction can thus be made between two
modes of transcriptional regulation: (i) direct regulation,
which is independent of protein synthesis (and concerns
IEG induction), and (ii) indirect regulation, which
requires preliminary IEG induction (and concerns target
gene control). A cascade of gene induction, involving
upstream IEGs and downstream targets, represents an
attractive model to explain how beta cell can bridge the
time gap between relatively short-lived stimuli and long
term cellular adaptation of gene expression. [18]
The aims of the study were, first, to identify targets at a
large scale in order to evaluate the importance of indirect
regulation of gene transcription, second, to define the cel-
lular functions concerned, and third, to verify the regula-
tory link between specific IEG transcription factors and
targets.
We have designed a genome-scaled approach to identify
glucose and cAMP-induced IEGs and their targets. Data-
base annotation searches were applied to infer cellular
functions of these genes. In silico analysis of target gene
promoters as well as gain and loss of function experiments
were performed to establish the link between specific IEGs
and target gene induction.
The data reported here suggest that a large part of gene
expression induced upon beta cell stimulation is regulated
by indirect mechanisms requiring preliminary IEG induc-
tion. Functions attributed to gene products cover a large
spectrum of cellular processes for both IEG and targets,
including metabolism, secretion, control of cell growth,
signal transduction and regulation of transcription.
Results
Identification and validation of glucose- and cAMP-
regulated IEGs and targets
To identify genes regulated by metabolic signals in beta
cells, we stimulated Min6 insulin-secreting cells with a
combination of elevated glucose (10 mM) and chloroph-
enylthio-cAMP (cpt-cAMP, 0.2 mM), a membrane-per-
meant cAMP analogue. Indeed, glucose induction of gene
expression is potentiated by gut hormones (such as gluca-
gon-like peptide-1, GLP-1) which raise cAMP [9]. Our ini-
tial transcript profile comparison using high density
oligonucleotide microarrays identified genes regulated by
a 4 hour treatment with glucose and cpt-cAMP (666 up-
regulated, 1204 down-regulated; fold change threshold of
1.5). Comparison with profiles obtained in presence of
the protein synthesis inhibitor cycloheximide (CHX)
allowed classifying each stimuli-responsive gene either as
IEG or as target. Indeed, by blocking protein neosynthesis,
CHX blocks synthesis of IEG products and their down-
stream regulatory action on target  transcription. Thus,
among the stimuli-responsive genes, those still regulated
in presence of CHX were defined as IEGs, while those no
longer regulated were defined as targets  (Figure 1, and
Additional file 1).
Among the 1870 regulated genes, 592 target genes were
identified (Table 1). Thus, a substantial part of the impactBMC Molecular Biology 2007, 8:54 http://www.biomedcentral.com/1471-2199/8/54
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produced by metabolic signals on beta cell transcriptional
program rely on the indirect action of IEG products.
To validate microarray data, we performed quantitative
RT-PCR analysis for a selected set of IEGs and target genes.
Comparison between fold-change values obtained from
microarray or RT-PCR experiments revealed that the
microarray data were of excellent quality (mean difference
between microarray and RT-PCR lower than 20%; see
Additional file 2). Furthermore, the CHX effect was con-
firmed by RT-PCR. Indeed, target regulation by glucose
and cAMP was abrogated in presence of CHX (Figure 2).
Furthermore, despite a small effect of CHX by itself on all
glucose-inducible IEGs examined, these were as strongly
stimulated by glucose and cAMP in the presence of CHX
as in its absence (Figure 2). Thus RT-PCR data validate the
selection of targets and IEGs based on the microarray data.
Functional classification of IEGs and targets
To address the functional role of IEGs and targets regu-
lated by glucose and cAMP in beta cells, we classified them
into functional categories based on the annotations in the
Swiss-Prot database (Figure 3) [19]. Of 755 glucose regu-
lated genes with annotations, more than 200 are involved
in signaling and transcription regulation. The large
number of IEGs involved in these two processes suggests
the importance of indirect mechanisms in gene regula-
tion. Moreover, an important fraction of target genes are
themselves involved in signal transduction and transcrip-
tional regulation.
Other important functional clusters include genes
involved in the secretory pathway, the metabolism or the
control of cell mass; processes that are known to be regu-
lated by glucose in beta cells [8]. Thus, the response of our
Min6 model is in agreement with previous knowledge on
the effect of metabolic stimuli on gene expression in beta
Validation of IEGs and targets by quantitative RT-PCR Figure 2
Validation of IEGs and targets by quantitative RT-
PCR. Induction of targets is inhibited in presence of CHX, 
while induction of IEGs is not. Min6 cells cultured at low glu-
cose for 20 hours were stimulated for 4 hours with 10 mM 
glucose and 0.2 mM cpt-cAMP, in presence or absence of 
CHX (5 μg/ml, added 45' prior to stimulation). mRNA levels 
for indicated genes were assessed by quantitative real-time 
RT-PCR and normalized with 18S rRNA. Results are 
expressed as mean of fold change compared to control con-
dition (s.d. as error bars, n = 5). *, p < 0.01; #, p < 0.05; NS: 
non significant vs respective control condition (i.e with or 
without CHX), by Student T-test.
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Table 1: Number of IEGs and target genes responding to glucose 
and cAMP identified in the transcript profiling experiment
IEGs targets total
Up-regulated 465 201 666
down-regulated 813 391 1204
Strategy to identify glucose and cAMP responsive IEGs and  their downstream targets Figure 1
Strategy to identify glucose and cAMP responsive 
IEGs and their downstream targets. A) IEGs (immediate-
early genes) are genes which are transcriptionaly inducible in 
a protein synthesis independent manner. IEG products regu-
late in turn the transcription of downstream targets. 
Cycloheximide (CHX), a protein synthesis inhibitor, blocks 
IEG product synthesis and subsequent activation of target 
transcription. B) Genes induced by glucose and cAMP com-
prise both IEGs and targets. Genes induced by glucose and 
cAMP in presence of CHX represent only IEGs. Note that 
CHX is also present in the control condition for this com-
parison. Target genes were deduced by subtraction between 
the gene lists.
IEGs targets
IEG mRNA target mRNA
Glucose and cAMP
stimulation
IEG
proteins
target
proteins
Transcriptional activation of
targets by IEG products
Cycloheximide(CHX)
A
B
Control vs stimulated
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Control vs stimulated
All responsive genes
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Only IEGs
target genes
Experimental
condition comparison:
Differentially
expressed genes:
Deduced gene
list:BMC Molecular Biology 2007, 8:54 http://www.biomedcentral.com/1471-2199/8/54
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cells. The genes involved in the secretory pathway con-
cerned with protein synthesis, translocation and folding
in the ER, glycosylation, vesicule transport, and exocyto-
sis, are detailed in the Additional file 3. Interestingly, an
important cluster of down-regulated genes is involved in
DNA damage checkpoint/repair pathways.
Noteworthy, the roles of IEG products are not restricted to
transcriptional regulation and cover a large panel of func-
tions (Figure 3 and Additional file 3). Thus, while on the
one hand, some IEGs can act indirectly by regulating
expression of target genes, on the other hand, different
IEGs can contribute directly to the functional adaptation
of beta cell to metabolic stimulation.
Target promoter analysis reveals the importance of AP-1 
transcription factor
To establish the link between IEGs that encode transcrip-
tion factors and their targets, we analyzed the promoters of
target genes. Predicted regulatory elements in target gene
promoters as well as in control sets of promoter (random
sets of promoters from genes expressed or not expressed
in Min6 cells) were gathered using the TFExplorer data-
base [20]. We then evaluated over- and under-represented
regulatory elements in targets promoters compared to con-
trol sets. 32 regulatory elements binding specific transcrip-
tion factors were significantly over-represented in glucose-
responsive target gene promoters (p < 0.05; Additional file
4). These include notably binding sites for E2F and DP-1
transcription factors found both in up-regulated and
down-regulated targets. But the most markedly over-repre-
sented regulatory element was an AP-1 binding site which
was present in 14% of the up-regulated targets (Figure 4).
Interestingly, this binding sequence was not enriched in
down-regulated targets. This suggests an important role for
AP-1 in transcriptional activation of target, and prompted
us to investigate its regulation in more details.
Glucose and cAMP regulate AP-1 complex composition 
and function
AP-1 binds DNA as a dimer composed of proteins of the
Fos and Jun families; forming either a Jun/Jun homo-
dimer or a Fos/Jun hetero-dimer [21]. Min6 cells main-
tained at low glucose predominantly expressed c-jun and
junD, indicating that the AP-1 complex is likely composed
of Jun/Jun homo-dimer (Table 2). Elevated glucose and
cAMP produced a robust 10 fold increase in c-fos and fosB
(IEGs), while c-jun  and  junD  expression was slightly
inhibited (Table 2 and data not shown). These results sug-
gest a potential shift in the composition of the AP-1 com-
plex toward Fos/Jun hetero-dimer and consequently a
possible alteration of AP-1 transactivating activity. To test
this possibility, we transfected cells with a luciferase
reporter gene under the control of an artificial promoter
harboring solely AP-1 sites as enhancers (pAP-1-luc; Fig-
ure 5A). Cells maintained at low glucose expressed the
reporter constitutively, likely reflecting the transcriptional
activation by the constitutive (Jun/Jun) AP-1 factors.
Despite this relatively high basal level of expression, glu-
AP-1 binding sites are over-represented in promoters of up- regulated targets Figure 4
AP-1 binding sites are over-represented in promot-
ers of up-regulated targets. Frequencies of promoters 
containing at least one AP-1 binding site were determined 
using TFExplorer predicted regulatory element database. 
Among the genes displayed on the microarray, absent genes 
were those with undetectable expression in Min6 and present 
genes were those with detectable expression in Min6. *, p < 
0.01 by Fisher exact test vs present genes.
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Functional clustering of glucose and cAMP responsive IEGs  and targets Figure 3
Functional clustering of glucose and cAMP respon-
sive IEGs and targets. From the list of glucose and cAMP 
regulated transcripts, we retrieved 755 genes with annota-
tions in Swiss-Prot database and clustered them according to 
functional categories. The diagram depicts the predominant 
clusters (gathering 534 genes); the 221 remaining genes were 
found in smaller clusters and are not represented.
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cose and cAMP still further stimulated the AP-1 reporter
expression significantly (Figure 5B).
Further experiments were performed to determine
whether the increased transcriptional activation by AP-1
could be explained by the induction of Fos genes. Min6
cells were co-transfected with pAP-1-luc and expression
vectors for c-fos and c-jun. At constant levels of the c-jun
vector, increasing amounts of transfected c-fos vector led
to a gradual increase in reporter gene expression (Figure
5C). Consistently, Fos/Jun hetero-dimers transactivate
more efficiently than Jun/Jun homo-dimers (see Addi-
tional file 5). Thus, the accumulation of c-fos gene product
is sufficient to enhance transcription of AP-1 regulated
genes.
In addition, we used A-FOS (a dominant negative form of
AP-1) to block endogenous AP-1 transcription factor [22].
Results demonstrate that endogenous AP-1 mediates the
transcriptional activation of the AP-1 reporter during
stimulation with glucose and cAMP (Figure 5D). As con-
trol, we used A-C/EBP (a dominant negative form of C/
EBP transcription factor, structurally but not functionally
similar to AP-1) which did not alter AP-1 reporter tran-
scription neither in basal nor in stimulated conditions.
We then determined if the transcriptional induction of
endogenous c-fos by glucose and cAMP would effectively
change the composition of DNA binding AP-1 complex.
Min6 cells were stimulated with glucose and glucagon-
like peptide-1 (GLP-1), a physiologically active glucoin-
cretin hormone which raises cAMP in beta cells [1]. Upon
stimulation, c-fos  mRNA induction was followed by a
marked increase in nuclear c-FOS protein, as seen by west-
ern blot analysis of nuclear extracts (Figure 5E), as well as
by immunocytochemistry (not shown). As a result, glu-
cose-induced FOS protein formed functional AP-1 com-
plexes (Figure 5F and 5G). This was shown by ELISA
quantification of the components of AP-1 complexes
binding to solid phase linked double stranded DNA with
the specific AP-1 consensus sequence. The strong correla-
Glucose and cAMP regulate transcriptional activation by AP- 1 through induction of AP-1 component expression Figure 5
Glucose and cAMP regulate transcriptional activa-
tion by AP-1 through induction of AP-1 component 
expression. A) Schematic representation of pAP-1-luc 
reporter. B) Min6 cells were transfected with pAP-1-luc (or 
control vector) and maintained at low glucose before stimu-
lation with glucose (10 mM) and cpt-cAMP (0.2 mM) for 6 
hours. C) Cells were transfected with AP-1 reporter (or 
control vector) and indicated quantity (in μg) of expression 
vector for c-fos and c-jun. D) pAP-1 reporter vector was co-
transfected with either A-FOS (a c-FOS dominant negative 
form), empty vector (control) or A-C/EBP as additional con-
trol (dominant negative form of C/EBP, a transcription factor 
structurally related to c-FOS). Stimulations were performed 
as under B. E,F,G) Min6 cells cultured at low glucose were 
stimulated with high glucose (10 mM) and GLP-1 (10 nM) for 
indicated period of time. Nuclear extracts were analyzed by 
western (E). Specific binding of c-FOS and JUND to AP-1 
sequence was measured in nuclear extracts with an ELISA-
like assay (F,G). E, F) representative of two repeated experi-
ments. #, p < 0.05 vs c-Jun alone (n = 3); *, p < 0.01 (n = 4), 
by Student T-test. Error bars: s.d.; ND: not determined.
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Table 2: Glucose and cAMP stimulation modulates the 
expression pattern of genes coding for AP-1 components
gene mean of microarray signal fold-change
control stimulated
c-fos 107 1'161 10.8*
fosB 66 0 1 0 . 7 *
fra-1 52 7 5 . 3
fra-2 71 458 7.0*
c-jun 249 205 -1.2
junB 59 275 4.6*
junD 811 647 -1.2
* significantly and consistently regulated IEGsBMC Molecular Biology 2007, 8:54 http://www.biomedcentral.com/1471-2199/8/54
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tion between accumulation of FOS in nuclear extracts and
its DNA binding activity indicates that newly synthesized
FOS protein is efficiently recruited to DNA-binding AP-1
complexes (Figure 5E versus 5F). In contrast to c-FOS, and
accordingly to a constant level of expression, JUND in
functional AP-1 complexes remained unchanged (Figure
5G).
The data in Figure 5 show that after glucose and cAMP
induction of fos- and jun-like IEGs, the newly synthesized
components are recruited to DNA binding AP-1 com-
plexes, notably shifting their composition to Fos/Jun het-
ero-dimers which are more potent trans-activators than
the constitutive Jun/Jun homo-dimers. Qualitative and
quantitative changes in the AP-1 complex may explain the
increased expression of a large number (14%) of glucose
up-regulated target genes. This mechanism involves tran-
scriptional induction of IEG and illustrates how IEGs and
their downstream targets are linked.
AP-1 regulates the transcription of the target gene 
sulfiredoxin (srxn1/npn3)
Having demonstrated that glucose and cAMP can activate
AP-1 transcription factor, we pursued our investigations
to identify which specific targets are effectively regulated
by AP-1. A candidate approach was undertaken. The most
strongly induced target gene in our system was sulfiredoxin
(srxn1, also known as npn3) and we identified three pre-
dicted AP-1 sites in its promoter; located 96, respectively
81 and 39 base pairs (bp) upstream of the transcriptional
start site. Srxn1 promoter regions from different sizes were
then cloned in front of a luciferase reporter gene and these
constructs were transfected in Min6 cells. Results of this
approach show that a narrow region of 81 bp containing
the three AP-1 sites is both sufficient and necessary to
srxn1 gene transcription in basal and stimulated condi-
tions (Figure 6A). Co-transfection with the A-FOS domi-
nant negative form of AP-1 impaired basal level of srxn1
reporter transcription and abolished stimuli responsive-
ness, indicating that AP-1 was necessary for these effects
(Figure 6B). In addition, ectopic expression of c-Fos was
sufficient to stimulate srxn1 reporter transcription (Figure
6C).
Finally, we established stably transfected Min6 cell lines
expressing A-FOS as well as control constructs. The down
regulation of AP-1 function in these stable clones was con-
firmed by assessing the transcriptional activation of a
transiently transfected pAP-1-luc reporter (Additional file
6). The expression levels of endogenous srxn1 was then
evaluated by quantitative RT-PCR (Figure 6D). While
junD mRNA levels (control) were constant among the dif-
ferent clones, both basal and stimulated srxn1 mRNA lev-
els were reduced in A-FOS clones. These effects were not
due to a defective stimuli-responsiveness in A-FOS clones
Srxn1 is a transcriptional target of AP-1 Figure 6
Srxn1 is a transcriptional target of AP-1. A) Depicted 
srxn1 reporter constructs were transfected in Min6 cells. 
Results as means of four independent experiments, with s.d. 
as error bars. *, p < 0.01 vs control; #, p < 0.01 vs corre-
sponding non-stimulated condition, by Student T-test. B) 
Depicted srxn1 reporter constructs were co-transfected 
respectively with A-FOS, A-C/EBP, or a control expression 
vector. Results as means of four independent experiments, 
with s.d. as error bars. *, #, p < 0.01, respectively p < 0.05 vs 
control expression vector, by Student T-test. For A) and B), 
stimulations were performed with 0.2 mM cpt-cAMP and 10 
mM glucose for 6 hours. C) srxn1-421/+39pGL3 reporter 
was cotransfected with c-fos expression vector (as in Figure 
5). Results as means of four independent experiments, with 
s.d. as error bars. *, p < 0.01 vs control expression vector, by 
Student T-test. D) mRNA levels for srxn1, junD and egr-1 
were quantified by RT-PCR in Min6 clones stably transfected 
with A-FOS, control expression vector and A-C/EBP respec-
tively. Stimulations were performed with 0.2 mM cpt-cAMP 
and 10 mM glucose for four hours. Four different cell prepa-
rations were analyzed for each of at least three clones in 
each category. Results were pooled and expressed as mean 
of relative mRNA levels (arbitrary units) with s.d. as error 
bars. *, p < 0.001 vs control, by Student T-test.
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since egr-1 IEG responded normally. In conclusion, data
in Figure 6 show that srxn1 is a downstream transcrip-
tional target of AP-1.
AP-1 and its target srnx1 are regulated by metabolic 
stimuli in primary pancreatic islets
Because some aspects of signaling in cell lines (like Min6)
may be altered by the transformation or the long term
maintenance in culture, we evaluated if our results could
be consistently reproduced in primary cells from isolated
islets.
Firstly, we evaluated the effects of metabolic stimuli on
expression of several IEG mRNA in isolated rat primary
islets (Figure 7). Glucose synergized with cpt-cAMP or
with GLP-1 to induce c-fos, fra-1, fra-2 and junB, while c-
jun and junD remained unaffected by these stimuli (Figure
7A and 7B). The pattern is identical to what was observed
in Min6 (Table 2). Furthermore, we observed induction of
egr-1 and nur77 (two IEGs encoding transcription factors
which were induced in Min6), indicating that the parallel
between Min6 and primary islets is not limited to AP-1.
Interestingly, dose-dependency experiments indicated
that maximal stimulation of IEGs was reached in presence
of GLP-1 and within a physiological (5 to 15 mM) range
of glucose concentrations (Figure 7C). Noteworthy, we
obtained similar synergistic activation of IEGs with iso-
lated (FACS sorted) beta cells stimulated with glucose and
GLP-1 (Additional file 7), respectively glucose and cpt-
cAMP (data not shown). Without excluding induction of
IEGs in other islet cell types (like glucagon-secreting cells
or somatostatin-secreting cells), these data indicate that
IEG mRNA accumulates in response to metabolic stimuli
in primary pancreatic beta cells.
Secondly, we investigated whether changes in IEG mRNA
levels were effectively followed by changes in protein lev-
els. c-FOS expression was thus assessed by immunocyto-
Induction of IEGs by metabolic stimuli in isolated rat islets Figure 7
Induction of IEGs by metabolic stimuli in isolated rat islets. Rat islets were isolated, cultured and serum deprived at 
reduced glucose concentration (1 mM) for 20 hours. Stimulation was done for one hour with 0.2 mM cpt-cAMP and/or 25 mM 
glucose (A); or with 10 nM GLP-1 and/or 25 mM glucose (B). mRNA levels for mentioned genes were quantified in triplicate by 
real-time RT-PCR, normalized with reference to 18S rRNA, and are shown as fold-increase over non-stimulated controls. 
Shown are the means of values obtained for three (A) or two (B) independent experiments (error bars = s.d.). Student T-tests 
were used for statistical analysis; *p < 0.05 vs non-stimulated; # p < 0.05 vs single stimulus conditions. C) Effect of various glu-
cose concentrations on the induction level of IEG expression (after one hour stimulation). Results as mean of at least two inde-
pendent experiments (s.d. as error bars).
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chemistry in dispersed islets (Figure 8A) and by western
blot analysis in nuclear extracts prepared from intact islets
(Figure 8B). Under low glucose conditions, immunofluo-
rescence staining of dispersed islets produced only a faint
background signal for c-FOS. Upon co-stimulation by glu-
cose and GLP-1 or cpt-cAMP, expression of c-FOS became
strongly apparent. c-FOS protein was mainly detected in
nuclei, co-localizing with DAPI staining for DNA. Co-
staining for insulin showed that nuclear c-FOS protein
was found in beta cells. Western blot analysis confirmed
the accumulation of c-FOS protein in the nucleus of pri-
mary islet cells. As depicted in Figure 8B, c-FOS protein
levels were nearly undetectable in islets maintained at low
glucose concentrations. Within 90 minutes of stimulation
by GLP-1 and elevated glucose, c-FOS became promi-
nently present in the nuclear extracts. Using cpt-cAMP as
co-stimulator with glucose led to a further increase in the
c-FOS signal on the western blots. Quantitatively, these
data on nuclear c-FOS protein corroborate observations
made at the mRNA level, with a strong effect of cpt-cAMP
and a more moderate effect of GLP-1 (Figure 8B), and are
similar to observations made in Min6 cells (Figure 5E,
Additional file 8 and data not shown).
Thirdly, we evaluated whether AP-1 regulation by meta-
bolic stimuli could be functional in islets. To that pur-
pose, expression levels of the newly identified AP-1 target
gene srxn1 were quantified by RT-PCR in isolated rat islets.
As in Min6 cells, co-stimulation with glucose and cpt-
cAMP, or glucose and GLP-1, induced significant accumu-
lation of srxn1 mRNA (Figure 9).
Altogether, data in Figures 7, 8, and 9 show that a func-
tional AP-1 regulation occurs in primary beta cells in
response to metabolic stimuli. This shows the potential
physiological relevance of the observations made in
Min6, and emphasizes the interest of the dataset obtained
with our screening approach in this cell line model.
Induction of srxn1 expression by metabolic stimuli in isolated  rat islets Figure 9
Induction of srxn1 expression by metabolic stimuli in 
isolated rat islets. Rat islets were isolated, cultured, and 
serum deprived at reduced glucose concentration (1 mM) for 
20 hours. Stimulation was done for indicated period of time 
with high glucose (25 mM) plus cpt-cAMP (0.2 mM) or GLP-1 
(10 nM). Transcript levels of the AP-1 target gene srxn1 were 
quantified by real-time RT-PCR, normalized with reference 
to 18S rRNA, and shown as relative values. Shown are the 
means of values obtained for at least three experiments. Stu-
dent T-tests were used for statistical analysis; *p < 0.05 vs 
non-stimulated; ** p < 0.01 vs non-stimulated.
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Accumulation of c-FOS protein in the nuclei of primary beta  cells upon metabolic stimulations Figure 8
Accumulation of c-FOS protein in the nuclei of pri-
mary beta cells upon metabolic stimulations. A) Islets 
were isolated, trypsin digested, cultured and serum deprived 
at low glucose concentration (1 mM) for 20 hours. After 60 
minutes of co-stimulation with 10 nM GLP-1 and 15 mM glu-
cose or 0.2 mM cpt-cAMP and 15 mM glucose, islets (50–100 
per condition) were fixed and analyzed by immunofluores-
cence staining of c-FOS (green) and of insulin (INS, red); 
nuclei were stained with the DNA reactive DAPI dye (violet). 
Fluorescence images shown separately for each dye or 
merged (c-FOS/DAPI; c-FOS/INS) are representative of 
three different experiments. Bar: 50 μm. B) Islets were iso-
lated, maintained and serum deprived at low glucose concen-
tration (1 mM) for 20 hours, prior to co-stimulation with 10 
nM GLP-1 and 15 mM glucose or 0.2 mM cpt-cAMP and 15 
mM glucose. After 90 minutes of stimulation, islets (~800 per 
condition) were trypsin digested, nuclear extracts were pre-
pared and c-FOS expression analyzed by western blotting. 
TFIIB was used as loading control.
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Discussion
The present study provides a comprehensive view on the
changes in gene transcription that occur within the first
hours after pancreatic beta cell stimulation with glucose
plus cAMP or incretin hormones. Induced IEGs and their
downstream targets were identified on a genomic scale.
Both IEGs and targets code for proteins involved in a large
spectrum of cellular functions, including those tightly
related to beta cell physiology, suggesting that these
inductions may mediate long term cellular adaptation.
Statistics on the response elements in target  promoters
pointed towards a predominant role of AP-1 composed of
IEG products of the fos and jun families. The mediator role
of AP-1 for the induction of a newly identified specific tar-
get (srxn1) was substantiated by expressing loss- and gain-
of-function mutants of c-fos.
Indirect mechanisms of gene regulation
The metabolic state of a pancreatic beta cell is translated
readily and without delay into insulin secretion which is
adjusted within minutes to altered glucose stimulation.
Such direct translation of metabolic state into regulated
expression is not possible for genes which change their
expression over much longer time frames (hours, days).
The transcriptional regulation of IEGs coding for tran-
scription factors according to beta cell metabolic activity
provides a mechanism by which target gene transcription
can be controlled over longer time frames. Increasing or
decreasing the presence of such transcription factors on
the promoters of target gene will affect the rate of tran-
scription. Here we illustrate this mechanism with the AP-
1 transcription factor, the importance of which is indi-
cated by the over-representation of AP-1 binding sites in
up-regulated target promoters. By modulating the pattern
of expression of the different AP-1 complex components
(notably through the strong induction of c-fos), glucose
and cAMP shift the composition of AP-1 dimer. The tran-
scriptional induction of c-fos by glucose and cAMP relies
on the activation of CaMkinase II and PKA which con-
verge to regulate cis-elements in its promoter (Susini et al.,
2000); in addition insulin signaling may also be involved,
as reported in other cell systems (Griffiths et al., 1998).
The shift in AP-1 composition increases transcriptional
activation of an AP-1 reporter gene, as well as at least one
endogenous AP-1 target (srxn1), showing that it has the
potential to affect numerous genes with an AP-1 binding
sequence in their promoters. Furthermore, the shift in AP-
1 composition (leading to a change in its transactivation
potential), as well as the up-regulation of srnx1  are
observed in cultured intact islets. Together with the obser-
vation of IEGs induction in vivo [10], this illustrates the
physiological relevance of our observations in the Min6
cell line.
The AP-1 example illustrate the complexity of indirect reg-
ulation, since this transcription factor exists in many com-
binations of JUN and FOS like proteins, some of which
are constitutive and some of which can be post-transla-
tionally modified. This gives rise to a whole repertoire of
AP-1 complexes with differential selectivity for distinct
AP-1 binding sites, varying trans-activation potential, and
differential interactions with other transcription factors
acting on the same promoter [23-25].
It should be mentioned that transcriptional activation, as
proposed here with the example of AP-1, is not the only
possible mechanism able to explain changes in mRNA
levels (as those quantified by microarrays and RT-PCR);
IEG products regulating target mRNA levels may also be
proteins involved in the control of mRNA degradation or
in the upstream signaling pathways that modulate the
activity of transcription factors and regulators of mRNA
stability.
Limitations
IEGs are defined as genes induced without the need for
protein de novo synthesis. IEGs are thus identified with the
use of protein synthesis inhibitors like CHX (cyclohex-
imide).
Results obtained with CHX have to be considered with
some caution. In addition to blocking protein synthesis,
CHX may also affect RNA and protein stability as well as
signaling pathways [26,27]. Design and interpretation of
our microarray experiments aimed to reduce the impact of
the non-specific effects of CHX to a minimum. We consid-
ered in our gene lists only those genes which responded to
stimulation when tested in the absence of CHX; thus,
CHX data were only used to separate IEGs from targets
within the list of stimuli-responsive genes. Furthermore,
in the experiments where cells were stimulated in the pres-
ence of CHX, induction was assessed against the CHX con-
trol conditions. Therefore, in our analysis, side effects of
CHX could have caused mis-labeling of responding genes
as IEGs or targets under very particular circumstances. As
these appear relatively unlikely, we are confident that the
large majority of genes are correctly listed. Indeed, the
detailed induction kinetic of several IEGs and targets genes
selected from these lists show distinct temporal patterns
of induction; the induction of all targets (7 genes ana-
lyzed) was delayed compared to the rapid induction of the
IEGs (4 genes analyzed) [18]. Moreover, in the present
study, we were able to verify the predictions about AP-1
based on the in silico target gene promoter analysis. Hence,
in spite of the limitations linked to using CHX, our micro-
array data represent a valid starting point to further
advance our understanding of the transcriptional
response of beta cells to metabolic signals.BMC Molecular Biology 2007, 8:54 http://www.biomedcentral.com/1471-2199/8/54
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The cellular function of glucose and cAMP regulated genes
Glucose and cAMP responsive genes form large clusters
functionally involved in secretion, metabolism, and beta
cell mass control (proliferation/apoptosis). Regulation
according to the metabolic state of such specific pancre-
atic beta cell functions is in agreement with previous stud-
ies [8,28]. However, a completely novel and unexpected
finding is that genes involved in DNA damage check-
point/repair represent a large down-regulated cluster. This
is consistent with the down-regulation of key transcrip-
tion factors governing this pathway (p53, foxo3) and some
downstream apoptosis effectors like bbc3, also known as
puma (Additional file 1) [29-31]. This raises intriguing
questions about the possible implication of DNA damage
pathway in the control of beta cell survival by glucose and
will require further investigations.
Srxn1 gene product sulfiredoxin reactivates peroxiredox-
ins (H2O2 scavenging enzymes) by catalyzing the reduc-
tion of sulfinic acids formed on peroxiredoxins following
exposure to excessive levels of H2O2 [32]. Recently, sulfire-
doxin was also shown to be involved in the reversal of
protein glutathionylation [33]. Thus, sulfiredoxin is
emerging as an important component in the cellular
redox signaling/control systems. To our knowledge, our
study provides the first report on the mechanisms of srxn1
gene transcriptional regulation in mammals. Regulating
the amount of sulfiredoxin in function of cell metabolic
stimulation (which is known to be associated with oxida-
tive stress and generation of H2O2 in beta cells [34]) con-
stitutes a feedback response susceptible to attenuate H2O2
effects and signaling.
Conclusion
The present study sheds light on the mechanisms by
which beta cell adapts its transcriptional program in
response to metabolic and hormonal stimuli known to
control secretion of insulin in the short term and prolifer-
ation, cell survival, and responsiveness in the long term.
Our findings on the role of the AP-1 transcription factor
as a mediator for the induction of srxn1 (sulfiredoxin) illus-
trate that IEG transcription factors may effectively relay
metabolic signals to regulate transcription of target genes
in beta cells.
The large number of induced target genes and the wide
array of cellular functions concerned suggest that indirect
mechanisms of gene regulation (through IEG induction)
likely play a substantial role in beta cell adaptation. How-
ever, the observation that a significant portion of IEGs
codes for proteins that are directly involved in adapted
cellular functions shows that direct induction of IEGs
transcription complements the indirect mode of gene reg-
ulation (Figure 10).
Methods
Chemicals
Cycloheximide (CHX), chlorophenylthio-cAMP (cpt-
cAMP) and glucagon-like peptide-1 (GLP-1) (7–37,
human) were purchased from Sigma (Buchs, Switzer-
land).
Min6 cell culture and incubations
Min6 B1 cells [35] (generously provided by Dr. Philippe
Halban, Dept of Development and Medical Genetics,
Medical faculty of Geneva University) (passage 15–25)
were cultured in DMEM supplemented with 15% fetal calf
serum, 25 mM glucose, 71 μM 2-mercaptoethanol, 100
units/ml penicillin, 100 μg/ml streptomycin and 50 μg/
ml gentamycin. Medium was changed to low glucose
medium (same as above with 1% FCS and 1 mM glucose)
20 hours before a 4 hour stimulation with glucose (10
mM) and cpt-cAMP (0.2 mM). When used, CHX (5 μg/
ml) was added 45' prior to stimulation.
Islet and primary beta cell isolation, culture and 
incubations
7-Week-old male Wistar rats (~250 g) were purchased
from Elevage Janvier (Le Genest-St-Isle, France). Pancre-
atic islets were isolated by collagenase digestion, hand-
picked, and maintained in 11.1 mM glucose/RPMI 1640
(Invitrogen) supplemented with 10% fetal calf serum
(Amimed, BioConcept Allschwil, Switzerland), 100 units/
ml penicillin, 100 μg/ml streptomycin and 50 μg/ml gen-
tamycin (Sigma).
Cellular adaptation to physiologically relevant stimuli occur- ring via a combination of direct and indirect modes of tran- scriptional control Figure 10
Cellular adaptation to physiologically relevant stimuli 
occurring via a combination of direct and indirect 
modes of transcriptional control. IEG products have 
two modes of action in the cellular adaptation to metabolic 
signals. Some IEG products act indirectly by controlling tran-
scription of target genes. Other IEG products are involved 
directly in regulated cellular processes. A coherent adapta-
tion of these processes requires the combined action of both 
IEG and target gene products.
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For the induction experiments, islets were maintained for
48 hours after isolation and serum deprived for 20 hours
in low glucose medium (1 mM glucose RPMI 1640 (Invit-
rogen), 0.1% BSA and same antibiotics as above). Consec-
utively, islets were stimulated with glucose, GLP-1 or cpt-
cAMP as detailed in the respective figure legends.
For beta cell purification, islets were trypsin digested and
FACS sorted as earlier described [36]. Beta cells were
maintained in 11.1 mM glucose/Dulbecco's modified
Eagle's medium (DMEM) (Invitrogen) supplemented
with 10% fetal calf serum and same antibiotics as above,
for five days to permit re-aggregation in small clusters. 20
hours before stimulation cells were serum deprived in low
glucose medium (1 mM glucose/DMEM supplemented
with 0.1% BSA, and same antibiotics as above).
RNA preparation and microarray analysis
All the stimulations were performed at the same time (in
parallel), with an unique batch of cells plated at uniform
confluence. For each experimental condition, transcript
profiles were established for three different preparations
of total RNA made using RNeasy Micro Kit (Qiagen).
Labeled cRNA synthesis, hybridization to the arrays and
scanning were essentially performed as earlier described
[37]. Affymetrix Mouse Genome 430 2.0 oligonucleotide
array (containing probe features for 45'101 transcripts)
were used. Fluorescence signals from the arrays were ana-
lyzed with Affymetrix software GCOS for normalization
and calculation of gene-expression values [38,39].
Criteria to define differentially expressed transcripts
The definition of differentially expressed transcripts
between two experimental conditions was based on three
criteria: concordance between replicates, statistical signif-
icance and fold-change cutoff. The strategy to evaluate the
concordance of an effect in two different experimental
conditions was the following: each replicate of one condi-
tion was compared to each replicate of the other, resulting
in 9 pairwise comparisons. Transcripts were considered as
differentially expressed if their levels changed in the same
direction in at least 7/9 comparisons. The second criterion
was a p value by Welch T test below 0.05 when comparing
signal values in two experimental conditions. Finally, the
third criterion was a minimal fold-change values of 1.5.
Criteria to delineate IEGs and targets
We considered genes that were differentially expressed in
control (no stimulation) vs stimulated (glucose + cAMP)
condition; these representing glucose and cAMP regulated
genes. We divided this list of genes into two lists: IEGs and
targets. To do so, different criteria were used.
Main criterion
The main criterion was the responsiveness in presence of
CHX. From the initial list of regulated genes, we consid-
ered genes that were differentially expressed in con-
trol+CHX  (no stimulation in presence of CHX) vs
stimulated+CHX  (glucose + cAMP in presence of CHX)
conditions; these represent IEGs (genes that respond to
glucose and cAMP in presence of CHX). The rest of the
genes (that were initially found to respond to glucose and
cAMP but were not regulated in presence of CHX) were
defined as targets. This single criterion is very stringent for
the definition of IEGs, but may lead, on the other hand, to
a high level of false positive in the target category. This is
particularly unsuitable, notably for the validity of target
promoter sequence analysis. Thus it was necessary to
introduce more criteria to increase the quality of target list.
Criteria to increase target list quality (secondary criteria)
Some genes responded to CHX alone. If CHX produces
more effect than glucose, it can mask the effect of glucose
in presence of CHX (saturating regulation by CHX). For
this reason, IEGs can be falsely considered as targets with
the main criterion (here-above). Thus we excluded from
up-regulated target gene list, the genes for which expres-
sion was higher in either control+CHX or stimulated+CHX
conditions compared to the stimulated condition. Simi-
larly, we excluded from down-regulated target gene list,
the genes for which expression was lower in either con-
trol+CHX or stimulated+CHX conditions compared to the
stimulated condition. Finally, we excluded from the target
list, genes for which the mean signal difference between
stimulated+CHX and control represented more than 25% of
the signal in the stimulated  condition. Genes excluded
from the target list by these secondary criteria were attrib-
uted to the IEG list.
Quantitative real-time RT-PCR
Each total RNA sample was reverse-transcribed in tripli-
cate with random hexamers as primers and Omniscript
reverse transcriptase (Qiagen). Quantitative real-time PCR
were performed with the SYBR Green system as described
in Brun et al. [40]. Primers were provided by Microsynth
(Balgach, Switzerland) and their sequences are presented
in Additional file 9. For normalization, 18S RNA was
quantified in each sample using 0.3× 18S rRNA Predevel-
oped Assay Reagent and 1× TaqMan® Universal PCR Mas-
ter Mix (Applied Biosystems).
PCR amplicons were quality controlled and all displayed
a single homogeneous melting curve as well as the correct
size on 2% agarose gels. A cDNA serial dilution standard
curve was added to the microtiter plate of each amplifica-
tion reaction to calibrate each relative quantification in
function of PCR amplification efficiency.BMC Molecular Biology 2007, 8:54 http://www.biomedcentral.com/1471-2199/8/54
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Promoter analysis
TFExplorer predicted regulatory element database [20]
was used to map regulatory elements in promoters (from
-1000 bp to +300 bp from transcription start site)
(accessed on June 17th 2005 [41]). We analyzed promot-
ers of target genes (132 up-regulated gene promoters, 239
down-regulated gene promoters) and of two control sets
of promoters from genes randomly chosen among those
present (detectable in Min6 cells, 1188 promoters) or
those absent (undetectable in Min6 cells, 1164 promot-
ers). For each promoter set (up-regulated targets, down-
regulated targets and controls) we counted the number of
promoters (Hit numbers) in which a given regulatory ele-
ment was present (at least once). We calculated the fre-
quencies for any given regulatory element within each set,
and evaluated the statistical significance of the difference
to the control sets by Fisher exact test.
Nuclear extract preparation and DNA binding assay
Nuclear protein extracts were prepared according to the
protocol of Schreiber et al.[42]. The detection of c-FOS
and JUND specific binding to AP-1 site was made with the
ELISA-like TransFactor Kit Inflammation II (BD Biosciences
AG, Switzerland) according to supplier instructions except
that the colorimetric detection step was replaced by a
chemiluminescent one. Briefly, after initial blocking, 12
μg of nuclear extracts were incubated 60 minutes in AP-1
or STAT consensus oligo coated 96-well plates. Plates were
then washed three times, incubated 60 minutes with pri-
mary antibodies (anti-c-FOS or anti-JUND), washed three
times and incubated 30 minutes with HRPO-anti-rabbit-
IgG secondary antibody (Transduction Laboratories)
(1:10'000). After final four washes, 100 μl of 1× ECL HRP
substrate (Cell Signaling Technology) were added to each
well and light emission measured three times with a FLU-
OStar OPTIMA (BMG LABTECH GmbH). Binding to
coated STAT oligo and competition with soluble AP-1
oligo were used to check binding specificity. Results were
expressed in arbitrary units of DNA binding after normal-
ization by values of no template controls (NTC) for each
independent experiment.
Srxn1 reporter construction
Srxn1 promoter regions of three different sizes (-421/+39;
-109/+39; -28/+39 from the transcriptional start site) were
amplified by PCR. Primer were designed from sequences
found in ENSEMBL database (entry:
ENSMUST00000041500) with addition of 5' flanking res-
idues to create restriction sites (XhoI for forward primers,
HindIII for the reverse primer; allowing directional inser-
tion). Three different forward primers were used srxn1-
421, AACTCGAGAGACAGCGCTGGGATCCAA; srxn1-
109, AACTCGAGGGCCTGAGTCACCACGCT; srxn1-28,
AACTCGAGCGTCCATTGAGCGCATCG (XhoI site in
bold). A single reverse primer was used srxn1+39: GAT-
TAAGCTTCTGACCTAGCTGCCCACTGCC (HindIII site
in bold). PCR products were initially cloned into pGEMT-
easy vector (Promega) using Takara mighty mix DNA liga-
tion kit (Takara Bio Inc.) and sequentially restriction
digested with HindIII and XhoI (Roche). Inserts of respec-
tive expected sizes were cloned into pGL3enhancer vector
(Promega) that had been previously restriction digested
with the same enzymes and treated with alkaline phos-
phatase (Roche). Construction sequences were verified by
the Dye Terminator sequencing technique using
Rvprimer3 (CTAGCAAAATAGGCTGTCCC) at the DNA
sequencing facility of Geneva University Medical Center.
Luciferase reporter analysis
0.5  μg PathDetect®  cis-Reporting System pAP-1-Luc or
pCIS CK (negative control) plasmids (Stratagene Europe,
Amsterdam Zuidoost, The Netherlands) were co-trans-
fected with 0.5 μg of Renilla luciferase plasmid (for nor-
malization) (Promega, Luzern, Switzerland) using
Lipofectamine 2000 reagent (Invitrogen) according to
supplier's instructions. In the ectopic expression experi-
ment, pMSCV-c-Fos (c-Fos expression vector) and/or
pMSCV-c-JunFlag (c-Jun expression vector) [43] (both
generously provided by Dr. Gerald Thiel, University of
Saarland Medical Center, Germany) were cotransfected at
various concentrations (see figure legends). Luciferase
activity measurement was performed 24 hours after the
transfection as previously described [14]. In stimulation
experiments, cells were transfected with reporter vectors,
maintained for 20 hours in culture medium, changed to
low glucose medium for additional 20 hours, and stimu-
lated for 6 hours with 10 mM glucose and 0.2 mM cpt-
cAMP (in triplicate).
AP-1 loss-of-function experiments
pCMV500 (control), pCMV500-A-FOS and pCMW500-A-
C/EBP (kind gift of Dr. Charles Vinson, National Cancer
Institute, Laboratory of Metabolism, Bethesda, MD, USA)
were used in transient co-transfection with reporter con-
structs or for establishment of stable transfectant Min6
clones. In the latter case, after transfection, 400 mg/l G418
were added to culture medium for a selection period of
one month. Clones were picked-up and grown in culture
medium supplemented with 200 mg/l G418. A decrease
in AP-1 reporter was specifically found in A-FOS clones
transiently transfected with pAP-1-luc (Additional file 6).
At least three different clones for each construct were used
in the experiments.
Western blotting and immunocytochemistry
Nuclear extracts (15 μg) were resolved on SDS-PAGE
(10% gel) and subject to immunoblot analysis as earlier
described [44]. Primary antibodies were rabbit anti-c-FOS
(1:1'000, sc-52) and anti-TFIIB (1:10'000, sc-225) (Santa
Cruz Biotechnology, Inc.). For immunofluorescence stud-BMC Molecular Biology 2007, 8:54 http://www.biomedcentral.com/1471-2199/8/54
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ies, partially trypsin dispersed rat islets were cultivated
and pre-incubated in low glucose RPMI 1640 medium as
described above for intact islets. After stimulation, cells
were subjected to cytospin on SuperFrost®Plus slides
(Menzel GmbH and Co KG, Braunschweig, Germany)
and fixed in 4% paraformaldehyde pH 7.0 for 30 minutes
at room temperature. After three PBS washes and two
incubations with boiling 10 mM citrate pH 6.0 for two
minutes, cells were permeabilized with 0.2% Triton PBS
for 15 minutes. Primary antibody for c-FOS (rabbit anti-c-
FOS, 1:200, sc-52, Santa-Cruz Biotechnology) and mouse
anti-insulin (1:1000, I-2018, Sigma) were diluted in
0.05% triton PBS and used for an overnight incubation.
After three washes, cells were incubated one hour with
secondary antibodies (alexa-488 labeled anti-rabbit-IgG
and alexa-568 labeled anti-mouse-IgG (both 1:300;
Molecular Probes)). After washings, cells were incubated
three minutes in 5 mg/ml 4',6-Diamidino-2-phenylindol
(DAPI), washed three times and mounted in Dakocyto-
mation fluorescent mounting medium (DakoCytomation
AG, Untermüli, Switzerland). Images were acquired with
a Zeiss Axiocam Imaging System (Bioimaging Core Facil-
ity, Medical Faculty, Geneva University).
Numbers of repeated experiments
In the figure legends, n represents the number of repeated
experiments. This corresponds to different cell prepara-
tions (in the case of islets, preparation from different rats).
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